LDLR and diabetic kidney disease: In support of this observation, TNFα is a major predictor of DKD progression in T1D and T2D (158–160) and inflammatory cytokines, such as TNFα or IL-1β, were shown to modify cholesterol-mediated LDL receptor regulation in mesangial cells.